Lucite commemorative marking the first patient dosed in a clinical study involving LunAIRo. Developed by Apnimed, the drug is intended for the treatment of obstructive sleep apnea. (23AZH173)
Lucite commemorative marking the first patient dosed in a clinical study involving LunAIRo. Developed by Apnimed, the drug is intended for the treatment of obstructive sleep apnea. (23AZH173)
Diamond-shaped crystal deal toy commemorating a follow-on stock offering by Swiss biotech firm Oculis. (23AKL262)
Custom Lucite with an embedded drug vial commemorating FDA approval of ELAHERE. Developed by ImmunoGen, the drug was granted accelerated FDA approval as a treatment for ovarian cancer. (23AKL266)
Crystal commemorative marking a licensing and commercialization agreement between Corbus Pharmaceuticals and CSPC Pharmaceutical Group. The agreement centers on a potential treatment for tumors associated with lung, breast, and prostate cancers. (23AZH089)
Custom Lucite commemorative celebrating a strategic partnership involving New Jersey-based Riverside Oral Surgery. (22AZH222)
Lucite commemorative, incorporating a drug vial, celebrating the first product shipment by generic pharmaceutical company Civica.
(9AKL475)Custom Lucite commemorating seed financing for Martin Pharmaceuticals. The design replicates the packaging for LIVANTRA, an orphan drug for the treatment of Acute-on-Chronic Liver Failure (ACLF). (8AMF069)
